Catalyst Wire Dossier Catalyst Wire Dossier

Trametinib (Mekinist)

trametinib · Novartis
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Trametinib (Mekinist), covering 2015-12-11 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation [Phase 2]

See pricing